Literature DB >> 6794079

Monoamine oxidase activity and enzyme kinetics in three subpopulations of density-fractionated platelets in chronic paranoid schizophrenics.

J J Mann, R D Kaplan, A Georgotas, E Friedman, M Branchey, S Gershon.   

Abstract

Platelet monoamine oxidase (MAO) activity was studied in three subpopulations of density-fractionated platelets in 15 unmedicated chronic paranoid schizophrenic patients and contrasted with normal controls. No significant difference in MAO activity was found in any of the three platelet fractions in schizophrenics compared to controls. Enzyme kinetic studies performed on the intermediate-density platelet fraction demonstrated no significant differences in Vmax or Michaelis' constant (Km) between schizophrenics and controls, but showed that the higher platelet MAO activity reported in females compared to male is due to a significantly greater Vmax rather than altered Km. It is suggested that conflicting results reported in the literature regarding platelet MAO in schizophrenia are not related to the platelet subpopulations studied but are largely due to the selected patient populations.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6794079     DOI: 10.1007/BF00432744

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  23 in total

1.  Monoamine oxidase activity in different density gradient fractions of human platelets.

Authors:  D L Murphy; J L Costa; B Shafer; L Corash
Journal:  Psychopharmacology (Berl)       Date:  1978-10-31       Impact factor: 4.530

2.  Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients.

Authors:  J J Schildkraut; J M Herzog; P J Orsulak; S E Edelman; H M Shein; S H Frazier
Journal:  Am J Psychiatry       Date:  1976-04       Impact factor: 18.112

3.  Megakaryocytes and the heterogeneity of circulating platelets.

Authors:  D G Penington; K Streatfield; A E Roxburgh
Journal:  Br J Haematol       Date:  1976-12       Impact factor: 6.998

4.  Platelet monoamine oxidase in chronic schizophrenia.

Authors:  W H Berrettini; W H Vogel; R Clouse
Journal:  Am J Psychiatry       Date:  1977-07       Impact factor: 18.112

5.  Monamine oxidase in schizophrenia and other behavioral disorders.

Authors:  D L Murphy; R Belmaker; R J Wyatt
Journal:  J Psychiatr Res       Date:  1974       Impact factor: 4.791

6.  Platelet monoamine oxidase in schizophrenia.

Authors:  R H Belmaker; A Reches; R P Ebstein
Journal:  Lancet       Date:  1977-10-15       Impact factor: 79.321

7.  Monoamine oxidase in chronic schizophrenia: Studies of hormonal and other factors affecting enzyme activity.

Authors:  D L Murphy; R Belmaker; W T Carpenter; R J Wyatt
Journal:  Br J Psychiatry       Date:  1977-02       Impact factor: 9.319

8.  Research diagnostic criteria: rationale and reliability.

Authors:  R L Spitzer; J Endicott; E Robins
Journal:  Arch Gen Psychiatry       Date:  1978-06

Review 9.  Platelet monoamine oxidase activity in schizophrenia: a review of the data.

Authors:  R J Wyatt; S G Potkin; D L Murphy
Journal:  Am J Psychiatry       Date:  1979-04       Impact factor: 18.112

10.  Are paranoid schizophrenics biologically different from other schizophrenics?

Authors:  S G Potkin; H E Cannon; D L Murphy; R J Wyatt
Journal:  N Engl J Med       Date:  1978-01-12       Impact factor: 91.245

View more
  2 in total

1.  Central catecholamine metabolism in vivo and the cognitive and motor deficits in Parkinson's disease.

Authors:  J J Mann; M Stanley; R D Kaplan; J Sweeney; A Neophytides
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-10       Impact factor: 10.154

2.  Platelet monoamine oxidase activity and schizophrenia--a myth that refuses to die?

Authors:  A Fleissner; R Seifert; K Schneider; W Eckert; B Fuisting
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1987
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.